Trial Profile
The effectiveness of Cholestimide on dyslipidemia with visceral fat accumulation in patients with type 2 diabetes. A randomized parallel crossover trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 May 2016
Price :
$35
*
At a glance
- Drugs Colestilan (Primary) ; HMG-CoA reductase inhibitors
- Indications Dyslipidaemias
- Focus Therapeutic Use
- 27 Jan 2014 According to University Hospital Medical Information Network - Japan record, status changed from active, no longer recruiting to completed.
- 21 Aug 2013 New trial record